We wish you to inform you that the board of director of asarfi hospital limited at its meeting held on 08Th May,2025 has considered and approved the audited statndalone and consolidated ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Asarfi Hospital Limited reported strong results for FY25 with standalone revenue from operations rising to ₹12,056.57 lakhs, up about 43% from ₹8,440.04 lakhs in FY24. Profit after tax jumped to ₹1,097.97 lakhs from ₹421.22 lakhs, a growth of roughly 161%, and EPS rose to ₹5.58 from ₹2.33. Q4 standalone revenue grew about 41% year-on-year to ₹3,389.20 lakhs, with PAT of ₹382.86 lakhs compared to a small loss last year. Consolidated FY25 revenue stood at ₹12,056.57 lakhs with PAT of ₹1,057.62 lakhs, also showing strong growth. The board appointed M/s R. K. Thakkar & Co as statutory auditor for FY24-25, and the auditor issued an unmodified (clean) opinion on the results.
Positive for shareholders: revenue and profits grew sharply, and margins expanded, suggesting strong operational performance. However, long-term borrowings nearly doubled and operating cash flow turned negative (₹-384 lakhs vs ₹2,592 lakhs last year), with trade receivables rising sharply — investors should watch for working capital and debt sustainability concerns despite the strong headline numbers.